Loading...
Photocure ASA
PHCUF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$6.00
$0.00(0.00%)
Photocure ASA (PHCUF) Financial Performance & Income Statement Overview
Review Photocure ASA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
4.94%
↑ 4.94%
Operating Income Growth
-26.64%
↓ 26.64%
Net Income Growth
-591.32%
↓ 591.32%
Operating Cash Flow Growth
58.88%
↑ 58.88%
Operating Margin
6.75%
↑ 6.75%
Gross Margin
93.97%
↑ 93.97%
Net Profit Margin
0.13%
↑ 0.13%
ROE
0.14%
↑ 0.14%
ROIC
5.94%
↑ 5.94%
Photocure ASA (PHCUF) Income Statement & Financial Overview
Review Photocure ASA's (PHCUF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $141.68M | $120.22M | $145.45M | $118.03M |
| Cost of Revenue | $7.49M | $7.86M | $14.82M | $14.86M |
| Gross Profit | $134.19M | $112.37M | $130.63M | $103.17M |
| Gross Profit Ratio | $0.95 | $0.93 | $0.90 | $0.87 |
| R&D Expenses | $104000.00 | $1.64M | $1.10M | $783000.00 |
| SG&A Expenses | $98.11M | $83.88M | $87.002M | $79.11M |
| Operating Expenses | $133.009M | $112.37M | $95.30M | $79.89M |
| Total Costs & Expenses | $140.50M | $120.22M | $102.92M | $94.75M |
| Interest Income | $6.23M | $6.90M | $5.24M | $6.52M |
| Interest Expense | $6.24M | $9.65M | $9.73M | $11.28M |
| Depreciation & Amortization | $7.27M | $7.21M | $7.19M | $7.12M |
| EBITDA | $14.69M | $11.93M | $27.85M | $14.39M |
| EBITDA Ratio | $0.10 | $0.10 | $0.19 | $0.12 |
| Operating Income | $1.18M | $0.00 | $42.52M | $23.28M |
| Operating Income Ratio | $0.008 | $0.00 | $0.29 | $0.20 |
| Other Income/Expenses (Net) | -$8000.00 | -$4.94M | -$26.36M | -$27.29M |
| Income Before Tax | $1.18M | -$4.94M | $16.16M | -$4.006M |
| Income Before Tax Ratio | $0.008 | -$0.04 | $0.11 | -$0.03 |
| Income Tax Expense | $6.96M | -$1.48M | $3.83M | $3.88M |
| Net Income | -$5.79M | -$3.47M | $12.33M | -$7.89M |
| Net Income Ratio | -$0.04 | -$0.03 | $0.08 | -$0.07 |
| EPS | -$0.21 | -$0.13 | $0.45 | -$0.29 |
| Diluted EPS | -$0.21 | -$0.13 | $0.45 | -$0.29 |
| Weighted Avg Shares Outstanding | $27.55M | $26.66M | $27.40M | $27.11M |
| Weighted Avg Shares Outstanding (Diluted) | $27.55M | $26.66M | $27.40M | $27.11M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan